Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Davignon

Showing results (231-240 of 236) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 236 results.
The Journal of Biological Chemistry|January 25, 1992
Two naturally occurring mutations at the first and second bases of codon aspartic acid 156 in the proposed catalytic triad of human lipoprotein lipase. In vivo evidence that aspartic acid 156 is essential for catalysisY H Ma, T Bruin, S Tuzgol, et al.
Journal of Lipid Research|August 1, 1990
Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemiaT L Innerarity, R W Mahley, K H Weisgraber, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 1997
Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrateT C Ooi, T Heinonen, P Alaupovic, et al.
Journal of Medical Genetics|August 19, 2008
A PCSK9 variant and familial combined hyperlipidaemiaM Abifadel, L Bernier, G Dubuc, et al.
JAMA|January 10, 1996
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemiaR G Bakker-Arkema, M H Davidson, R J Goldstein, et al.
Clinical Genetics|July 1, 1997
Geographic distribution of French-Canadian low-density lipoprotein receptor gene mutations in the Province of QuebecM C Vohl, S Moorjani, M Roy, et al.
Pageof 24

Showing results (231-240 of 236) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 236 results.
The Journal of Biological Chemistry|January 25, 1992
Two naturally occurring mutations at the first and second bases of codon aspartic acid 156 in the proposed catalytic triad of human lipoprotein lipase. In vivo evidence that aspartic acid 156 is essential for catalysisY H Ma, T Bruin, S Tuzgol, et al.
Journal of Lipid Research|August 1, 1990
Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemiaT L Innerarity, R W Mahley, K H Weisgraber, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 1997
Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrateT C Ooi, T Heinonen, P Alaupovic, et al.
Journal of Medical Genetics|August 19, 2008
A PCSK9 variant and familial combined hyperlipidaemiaM Abifadel, L Bernier, G Dubuc, et al.
JAMA|January 10, 1996
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemiaR G Bakker-Arkema, M H Davidson, R J Goldstein, et al.
Clinical Genetics|July 1, 1997
Geographic distribution of French-Canadian low-density lipoprotein receptor gene mutations in the Province of QuebecM C Vohl, S Moorjani, M Roy, et al.
Pageof 24